No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Bone Marrow / drug effects
-
Bone Marrow / pathology*
-
Cell Aggregation / drug effects
-
Child
-
Humans
-
Imatinib Mesylate / therapeutic use*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
-
Male
Substances
-
Antineoplastic Agents
-
Imatinib Mesylate